CIK 0001651308 · Large accelerated filer
BeOne Medicines Ltd.
Sign in to watch- Ticker
- BEIGF
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981209416
- Phone
- 41-616851900
- Business address
- C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
- Former names
- BeiGene, Ltd.
Securities
- ONC American Depositary Shares Nasdaq
- BEIGF Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $48,487,541
- in 9 filings, $47.8M under 10b5-1 plans
Net −$48,487,541. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-06 | Ball Titus B. Principal Accounting Officer | Option exercise | +880 | $207.55 | $183K | 880 |
| 2026-11-06 | Ball Titus B. Principal Accounting Officer | Option exercise | +679 | $159.03 | $108K | 1,559 |
| 2026-11-06 | Ball Titus B. Principal Accounting Officer | Sale | −1,533 | $405.55 | $622K | 26 |
| 2026-11-06 | Ball Titus B. Principal Accounting Officer | Sale | −26 | $406.34 | $11K | 0 |
| 2026-11-06 | Ball Titus B. Principal Accounting Officer | Option exercise · Share Option (Right to Buy) | −11,440 | 3,237 | ||
| 2026-11-06 | Ball Titus B. Principal Accounting Officer | Option exercise · Share Option (Right to Buy) | −8,827 | 6,513 | ||
| 2026-11-05 | Lee Chan Henry SVP, General Counsel | Sale 10b5-1 | −660 | $400.00 | $264K | 455 |
| 2026-11-05 | Lee Chan Henry SVP, General Counsel | Sale 10b5-1 | −455 | $402.00 | $183K | 0 |
| 2026-10-27 | Wang Xiaodong Director | Option exercise 10b5-1 | +31,028 | $36.90 | $1.1M | 31,028 |
| 2026-10-27 | Wang Xiaodong Director | Sale 10b5-1 | −880 | $355.56 | $313K | 30,148 |
| 2026-10-27 | Wang Xiaodong Director | Sale 10b5-1 | −1,440 | $355.62 | $512K | 28,708 |
| 2026-10-27 | Wang Xiaodong Director | Sale 10b5-1 | −1,239 | $357.54 | $443K | 27,469 |
| 2026-10-27 | Wang Xiaodong Director | Sale 10b5-1 | −1,681 | $358.75 | $603K | 25,788 |
| 2026-10-27 | Wang Xiaodong Director | Sale 10b5-1 | −1,280 | $359.72 | $460K | 24,508 |
| 2026-10-27 | Wang Xiaodong Director | Sale 10b5-1 | −320 | $360.64 | $115K | 24,188 |
| 2026-10-27 | Wang Xiaodong Director | Sale 10b5-1 | −2,331 | $362.35 | $845K | 21,857 |
| 2026-10-27 | Wang Xiaodong Director | Sale 10b5-1 | −8,148 | $363.24 | $3.0M | 13,709 |
| 2026-10-27 | Wang Xiaodong Director | Sale 10b5-1 | −2,841 | $363.95 | $1.0M | 10,868 |
| 2026-10-27 | Wang Xiaodong Director | Sale 10b5-1 | −3,965 | $365.43 | $1.4M | 6,903 |
| 2026-10-27 | Wang Xiaodong Director | Sale 10b5-1 | −6,903 | $366.22 | $2.5M | 0 |
Page 1 of 71 · 1,405 trades